The relationship between insulin, IGF-I and weight gain in cystic fibrosis.

OBJECTIVE: In cystic fibrosis, reduced body mass is related to low levels of IGF-I and changes in the IGF binding proteins. Our aim was to determine whether these abnormalities are linked to pancreatic endocrine dysfunction. PATIENTS AND DESIGN: We measured serum levels of insulin, IGF-I, IGFBP-I, I...

Full description

Bibliographic Details
Main Authors: Taylor, A, Thomson, A, Bruce-Morgan, C, Ahmed, M, Watts, A, Harris, D, Holly, J, Dunger, D
Format: Journal article
Language:English
Published: 1999
_version_ 1797082774471966720
author Taylor, A
Thomson, A
Bruce-Morgan, C
Ahmed, M
Watts, A
Harris, D
Holly, J
Dunger, D
author_facet Taylor, A
Thomson, A
Bruce-Morgan, C
Ahmed, M
Watts, A
Harris, D
Holly, J
Dunger, D
author_sort Taylor, A
collection OXFORD
description OBJECTIVE: In cystic fibrosis, reduced body mass is related to low levels of IGF-I and changes in the IGF binding proteins. Our aim was to determine whether these abnormalities are linked to pancreatic endocrine dysfunction. PATIENTS AND DESIGN: We measured serum levels of insulin, IGF-I, IGFBP-I, IGFBP-3 and IGF bioactivity in 77 fasting subjects (43 male) mean age 9.6 years (range 2.99-17.98 years). Data were analysed with respect of body mass, puberty and stature and compared with control data established in the same laboratory. RESULTS: The mean height standard deviation score (SDS (SD)) was -0.54 (0.97) and the body mass index SDS -0.24 (1.09). Both body mass index SDS (r = -0.40, P = 0.0003) and IGF-I SDS (r = - 0.32, P = 0.009) declined with age. Insulin levels were also low and correlated with IGF-I and IGFBP-3 (r = 0.42, P = 0.0004, and r = 0.45, P = 0.0002, respectively) whereas levels of IGFBP-I were inversely related to those of IGF-I and insulin (r = - 0.43, P = 0. 0004, r = - 0.52, P < 0.0001). IGF bioactivity was reduced and inversely related to IGFBP-I (r = - 0.31, P = 0.009). In multiple regression analysis, body mass index SDS was negatively related to age (P < 0.0001) and positively related to insulin and IGF-I (P = 0. 04, P = 0.03, respectively). Height SDS was correlated with IGF bioactivity (P = 0.003) and negatively with IGFBP-I (P = 0.01). CONCLUSIONS: We conclude that progressive insulin deficiency may result in reduced IGF-I levels and IGF-bioactivity and may determine weight gain and statural growth in cystic fibrosis.
first_indexed 2024-03-07T01:32:37Z
format Journal article
id oxford-uuid:9419bcbf-f132-47d1-ba26-338f74e42786
institution University of Oxford
language English
last_indexed 2024-03-07T01:32:37Z
publishDate 1999
record_format dspace
spelling oxford-uuid:9419bcbf-f132-47d1-ba26-338f74e427862022-03-26T23:36:54ZThe relationship between insulin, IGF-I and weight gain in cystic fibrosis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9419bcbf-f132-47d1-ba26-338f74e42786EnglishSymplectic Elements at Oxford1999Taylor, AThomson, ABruce-Morgan, CAhmed, MWatts, AHarris, DHolly, JDunger, DOBJECTIVE: In cystic fibrosis, reduced body mass is related to low levels of IGF-I and changes in the IGF binding proteins. Our aim was to determine whether these abnormalities are linked to pancreatic endocrine dysfunction. PATIENTS AND DESIGN: We measured serum levels of insulin, IGF-I, IGFBP-I, IGFBP-3 and IGF bioactivity in 77 fasting subjects (43 male) mean age 9.6 years (range 2.99-17.98 years). Data were analysed with respect of body mass, puberty and stature and compared with control data established in the same laboratory. RESULTS: The mean height standard deviation score (SDS (SD)) was -0.54 (0.97) and the body mass index SDS -0.24 (1.09). Both body mass index SDS (r = -0.40, P = 0.0003) and IGF-I SDS (r = - 0.32, P = 0.009) declined with age. Insulin levels were also low and correlated with IGF-I and IGFBP-3 (r = 0.42, P = 0.0004, and r = 0.45, P = 0.0002, respectively) whereas levels of IGFBP-I were inversely related to those of IGF-I and insulin (r = - 0.43, P = 0. 0004, r = - 0.52, P < 0.0001). IGF bioactivity was reduced and inversely related to IGFBP-I (r = - 0.31, P = 0.009). In multiple regression analysis, body mass index SDS was negatively related to age (P < 0.0001) and positively related to insulin and IGF-I (P = 0. 04, P = 0.03, respectively). Height SDS was correlated with IGF bioactivity (P = 0.003) and negatively with IGFBP-I (P = 0.01). CONCLUSIONS: We conclude that progressive insulin deficiency may result in reduced IGF-I levels and IGF-bioactivity and may determine weight gain and statural growth in cystic fibrosis.
spellingShingle Taylor, A
Thomson, A
Bruce-Morgan, C
Ahmed, M
Watts, A
Harris, D
Holly, J
Dunger, D
The relationship between insulin, IGF-I and weight gain in cystic fibrosis.
title The relationship between insulin, IGF-I and weight gain in cystic fibrosis.
title_full The relationship between insulin, IGF-I and weight gain in cystic fibrosis.
title_fullStr The relationship between insulin, IGF-I and weight gain in cystic fibrosis.
title_full_unstemmed The relationship between insulin, IGF-I and weight gain in cystic fibrosis.
title_short The relationship between insulin, IGF-I and weight gain in cystic fibrosis.
title_sort relationship between insulin igf i and weight gain in cystic fibrosis
work_keys_str_mv AT taylora therelationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT thomsona therelationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT brucemorganc therelationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT ahmedm therelationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT wattsa therelationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT harrisd therelationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT hollyj therelationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT dungerd therelationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT taylora relationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT thomsona relationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT brucemorganc relationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT ahmedm relationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT wattsa relationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT harrisd relationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT hollyj relationshipbetweeninsulinigfiandweightgainincysticfibrosis
AT dungerd relationshipbetweeninsulinigfiandweightgainincysticfibrosis